The University of Michigan
Ganesh S. Palapattu, MD, FACS is Chair of the Department and the George F. and Sandy G. Valassis Professor of Urology in the Department of Urology at the University of Michigan. Dr. Palapattu’s clinical interest is in the evaluation and management of men with high risk prostate cancer. As a surgeon-scientist, he currently maintains a prostate cancer translational lab in addition to his clinical duties. Dr. Palapattu graduated from Baylor College of Medicine and completed his surgical internship, urologic training and chief residency in urology at the David Geffen School of Medicine at UCLA. Following this, Dr. Palapattu completed a 2 year laboratory research fellowship in Urologic Oncology funded by the Urology Care Foundation (formerly American Foundation of Urologic Disease) at the Johns Hopkins Hospital/Brady Urological Institute. He then took a faculty appointment at the University of Rochester School of Medicine as an Assistant Professor. Dr. Palapattu was subsequently recruited to The Methodist Hospital/The Methodist Research Institute as Chief of Urologic Oncology and Associate Professor of Urology, Weill Cornell Medical College, in Houston, Texas where he continued his work as a surgeon-scientist. In the Spring of 2012, after a national search, he was recruited to the University of Michigan (UM) Department of Urology. The UM Division of Urologic Oncology, among the largest of its kind in the United States, is a national leader in urological cancer clinical care, research productivity and advanced medical education. Dr. Palapattu was selected as Chair of the Department in February 2019.
Dr. Palapattu’s research centers around prostate cancer: i) employing metabolomics to understand the biology of prostate cancer progression, ii) dissecting the role of tumor stromal-epithelial interactions in prostate cancer metastasis, iii) testing NK cell therapy in advanced urological cancer and iv) examining the function of platelets in the pathogenesis of cancer.
Disclosure information not submitted.
Thursday, April 27, 2023
3:00 PM – 3:30 PM CST